logo dark logo light logo
  • Home
  • About
    • Vision
    • Advantage
    • Global Reach
    • Investor Information
    • Media
    • Contact
  • Key Personnel
  • Research & Development
    • Comprehensive Platform
    • Diversified Cannabinoid Delivery Technologies
    • Research Collaborators
    • Sponsored Research Agreements
    • Intellectual Property Estate
  • Pharmaceuticals
    • Clinical Approach
    • Development Pipeline
  • Nutraceuticals
    • Consumer Products
    • Development Pipeline
    • Product Descriptions
    • QA/QC Criteria
    • Technology FAQs
  • Resources
    • CBD
    • WHO Report: Safety & Summary
    • Bioavailability
    • Research Publications
      • CBD Applications: Concussion
    • Cannabinoids
    • Bioavailability
    • ANANDA Scientific & Diabetes
    • ANANDA Scientific & Chronic Pain
    • First Product
    • ANANDA Standard™
    • CBD Grades
    • QA/QC Criteria
    • Material Safety Data Sheet
logo dark logo light logo
  • Home
  • About
    • Vision
    • Advantage
    • Global Reach
    • Investor Information
    • Media
    • Contact
  • Key Personnel
  • Research & Development
    • Comprehensive Platform
    • Diversified Cannabinoid Delivery Technologies
    • Research Collaborators
    • Sponsored Research Agreements
    • Intellectual Property Estate
  • Pharmaceuticals
    • Clinical Approach
    • Development Pipeline
  • Nutraceuticals
    • Consumer Products
    • Development Pipeline
    • Product Descriptions
    • QA/QC Criteria
    • Technology FAQs
  • Resources
    • CBD
    • WHO Report: Safety & Summary
    • Bioavailability
    • Research Publications
      • CBD Applications: Concussion
    • Cannabinoids
    • Bioavailability
    • ANANDA Scientific & Diabetes
    • ANANDA Scientific & Chronic Pain
    • First Product
    • ANANDA Standard™
    • CBD Grades
    • QA/QC Criteria
    • Material Safety Data Sheet
mobile-logo
  • Home
  • About
    • Vision
    • Advantage
    • Global Reach
    • Investor Information
    • Media
    • Contact
  • Key Personnel
  • Research & Development
    • Comprehensive Platform
    • Diversified Cannabinoid Delivery Technologies
    • Research Collaborators
    • Sponsored Research Agreements
    • Intellectual Property Estate
  • Pharmaceuticals
    • Clinical Approach
    • Development Pipeline
  • Nutraceuticals
    • Consumer Products
    • Development Pipeline
    • Product Descriptions
    • QA/QC Criteria
    • Technology FAQs
  • Resources
    • CBD
    • WHO Report: Safety & Summary
    • Bioavailability
    • Research Publications
      • CBD Applications: Concussion
    • Cannabinoids
    • Bioavailability
    • ANANDA Scientific & Diabetes
    • ANANDA Scientific & Chronic Pain
    • First Product
    • ANANDA Standard™
    • CBD Grades
    • QA/QC Criteria
    • Material Safety Data Sheet

Archive

a
29 Jul

Conference Home II

by
in
Comments
Read More
a
29 Jul

Conference Home

by
in
Comments
Read More

LATEST MEDIA

  • ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient enrolled in the Clinical Trial for Opioid Sparing in Participants with Radiculopathic Pain.
  • ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)
  • ANANDA Scientific’s Liquid Structure™ Cannabidiol (CBD) to be clinically evaluated for Opioid Use Disorder.
  • ANANDA Scientific and the David Geffen School of Medicine UCLA Announce a Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for the Treatment of Opioid Use Disorder (OUD).
  • ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)

CATEGORIES

logo

6080 Greenwood Plaza Blvd., Unit B
Greenwood Village, CO 80111
Phone: +1.385.241.3376
E-mail: admin@anandascientific.com

Company

  • Key Personnel
  • FAQ
  • Testimonials
  • Investor Information
  • Press Releases

Latest News

  • Ananda Scientific was very pleased to host its Annual Shareholders’ Meeting this week. The shareholders were provid… https://t.co/d0cordFX8J
    1 week ago
  • We have reached an impressive milestone with 6 ongoing FDA approved Clinical Trials for PTSD, Opioid Use Disorder,… https://t.co/C13X8yERjq
    2 weeks ago
  • Ananda Scientific has one core mission: To pioneer high caliber #clinical studies to evaluate some the most debilit… https://t.co/2xOW15pJs8
    3 weeks ago
Copyright © 2020 ANANDA Scientific, Inc. All Rights Reserved.